| Literature DB >> 35049501 |
Jeffrey Y Lee1, Peter A C Wing2,3, Dalia S Gala1, Marko Noerenberg1,4, Aino I Järvelin1, Joshua Titlow1, Xiaodong Zhuang2, Natasha Palmalux4, Louisa Iselin1, Mary Kay Thompson1, Richard M Parton1, Maria Prange-Barczynska2,5, Alan Wainman6, Francisco J Salguero7, Tammie Bishop2,5, Daniel Agranoff8, William James6,9, Alfredo Castello1,4, Jane A McKeating2,3, Ilan Davis1.
Abstract
Despite an unprecedented global research effort on SARS-CoV-2, early replication events remain poorly understood. Given the clinical importance of emergent viral variants with increased transmission, there is an urgent need to understand the early stages of viral replication and transcription. We used single-molecule fluorescence in situ hybridisation (smFISH) to quantify positive sense RNA genomes with 95% detection efficiency, while simultaneously visualising negative sense genomes, subgenomic RNAs, and viral proteins. Our absolute quantification of viral RNAs and replication factories revealed that SARS-CoV-2 genomic RNA is long-lived after entry, suggesting that it avoids degradation by cellular nucleases. Moreover, we observed that SARS-CoV-2 replication is highly variable between cells, with only a small cell population displaying high burden of viral RNA. Unexpectedly, the B.1.1.7 variant, first identified in the UK, exhibits significantly slower replication kinetics than the Victoria strain, suggesting a novel mechanism contributing to its higher transmissibility with important clinical implications.Entities:
Keywords: smFISH; B.1.1.7; COVID-19; SARS-CoV-2; cell biology; early replication; human; infectious disease; microbiology; single-molecule fluorescence in situ hybridisation; variant of concern; viruses
Mesh:
Substances:
Year: 2022 PMID: 35049501 PMCID: PMC8776252 DOI: 10.7554/eLife.74153
Source DB: PubMed Journal: Elife ISSN: 2050-084X Impact factor: 8.713